TABLE OF CONTENTS
Volume 31, Issue 12 (June (2) 2003)
Thalassaemia |
Acute Myeloid Leukaemia |
Histiocytic Disorders |
Hurler Syndrome |
Ex vivo Purging |
Minimal Residual Disease |
Infections Post Transplant |
Post-Transplant Complications |
Case Reports |
Correspondence |
Reply |
Corrigendum |
Author Index |
Keyword Index
CD34+ Cell Enrichment
High incidence of graft failure in children receiving CD34+ augmented elutriated allografts for nonmalignant diseases FREE
C H McDonough, D A Jacobsohn, G B Vogelsang, S J Noga and A R Chen
Bone Marrow Transplant 31: 1073-1080; doi:10.1038/sj.bmt.1704071
Thalassaemia
Paediatric allogeneic bone marrow transplantation for homozygous 
-thalassaemia, the Dutch experience FREE
L M Ball, A C Lankester, P C Giordano, M H van Weel, C L Harteveld, R G M Bredius, F J Smiers, R M Egeler and J M J J Vossen
Bone Marrow Transplant 31: 1081-1087; doi:10.1038/sj.bmt.1704066
Acute Myeloid Leukaemia
Reduced intensity conditioning for allogeneic hematopoietic stem cell transplantation in patients with acute myeloid leukemia: disease status by marrow blasts is the strongest prognostic factor FREE
H G Sayer, M Kröger, J Beyer, M Kiehl, S A Klein, K Schaefer-Eckart, R Schwerdtfeger, W Siegert, V Runde, C Theuser, H Martin, J Schetelig, D W Beelen, A Fauser, J Kienast, K Höffken, G Ehninger and M Bornhäuser on behalf of the Cooperative German Transplant Study Group (CGTG)
Bone Marrow Transplant 31: 1089-1095; doi:10.1038/sj.bmt.1704062
Histiocytic Disorders
Hematopoietic stem cell transplantation in patients with severe Langerhans cell histiocytosis and hematological dysfunction: Experience of the French Langerhans Cell Study Group FREE
V Akkari, J Donadieu, C Piguet, P Bordigoni, G Michel, S Blanche, J L Casanova, C Thomas, E Vilmer, A Fischer and Y Bertrand
Bone Marrow Transplant 31: 1097-1103; doi:10.1038/sj.bmt.1704065
Hurler Syndrome
Outcome of 27 patients with Hurler's syndrome transplanted from either related or unrelated haematopoietic stem cell sources FREE
G Souillet, N Guffon, I Maire, M Pujol, P Taylor, F Sevin, N Bleyzac, C Mulier, A Durin, K Kebaili, C Galambrun, Y Bertrand, R Froissart, C Dorche, L Gebuhrer, C Garin, J Berard and P Guibaud
Bone Marrow Transplant 31: 1105-1117; doi:10.1038/sj.bmt.1704105
Ex vivo Purging
Ex vivo purging with NK-92 prior to autografting for chronic myelogenous leukemia FREE
G Maki, Y K Tam, L Berkahn and H-G Klingemann
Bone Marrow Transplant 31: 1119-1125; doi:10.1038/sj.bmt.1704117
Minimal Residual Disease
Lack of clinical utility of minimal residual disease detection in allogeneic stem cell recipients with childhood acute lymphoblastic leukemia: multi-institutional collaborative study in Japan FREE
S Imashuku, K Terui, T Matsuyama, K Asami, S Tsuchiya, E Ishii, K Kawa, Y Kosaka, H Eguchi, M Tsuchida, K Ikuta, S Kato, S Koizumi, J Okamura, A Morimoto, S Hibi and K Hamaoka for the MRD Study Group in Allogeneic Bone Marrow Transplantation for Childhood ALL
Bone Marrow Transplant 31: 1127-1135; doi:10.1038/sj.bmt.1704067
Infections Post Transplant
Procalcitonin, C-reactive protein, and endotoxin after bone marrow transplantation: identification of children at high risk of morbidity and mortality from sepsis FREE
M Sauer, K Tiede, D Fuchs, B Gruhn, D Berger and F Zintl
Bone Marrow Transplant 31: 1137-1142; doi:10.1038/sj.bmt.1704045
Post-Transplant Complications
Low molecular weight heparin for the prevention of hepatic veno-occlusive disease (VOD) after hematopoietic stem cell transplantation: a prospective phase II study FREE
D L Forrest, K Thompson, V G Dorcas, S H Couban and R Pierce
Bone Marrow Transplant 31: 1143-1149; doi:10.1038/sj.bmt.1704087
Eye shielding during total body irradiation for bone marrow transplantation in children transplanted for a hematological disorder: risks and benefits FREE
M L van Kempen-Harteveld, M H van Weel-Sipman, C Emmens, E M Noordijk, I van der Tweel, T Révész, H Struikmans, H B Kal, A van der Does-van den Berg and J M J J Vossen
Bone Marrow Transplant 31: 1151-1156; doi:10.1038/sj.bmt.1704076
Idiopathic pneumonia syndrome after high-dose chemotherapy and autologous hematopoietic stem cell transplantation for high-risk breast cancer FREE
R Wong, G Rondon, R M Saliba, V R Shannon, S A Giralt, R E Champlin and N T Ueno
Bone Marrow Transplant 31: 1157-1163; doi:10.1038/sj.bmt.1704141
Case Reports
Successful treatment of bcr/abl-positive acute mixed lineage leukemia by unmanipulated bone marrow transplantation from an HLA-haploidentical (3-antigen-mismatched) cousin FREE
K Ikegame, C Mukouchi, A Kunitomi, Y Konaka, M Kawakami, S Nishida, Y Taniguchi, T Fujioka, T Masuda, M Murakami, N Hosen, E H Kim, A Tsuboi, Y Oji, Y Oka, H Sugiyama, I Kawase and H Ogawa
Bone Marrow Transplant 31: 1165-1168; doi:10.1038/sj.bmt.1704064
Successful treatment of natural killer (NK) cell leukemia following a long-standing chronic active Epstein–Barr virus (CAEBV) infection with allogeneic bone marrow transplantation FREE
Y Ebihara, A Manabe, R Tanaka, T Yoshimasu, K Ishikawa, T Iseki, J Hayakawa, M Maeda, S Asano and K Tsuji
Bone Marrow Transplant 31: 1169-1171; doi:10.1038/sj.bmt.1704078
Acute renal failure due to adenovirus-associated obstructive uropathy and necrotizing tubulointerstitial nephritis in a bone marrow transplant recipient FREE
K Mori, T Yoshihara, Y Nishimura, M Uchida, K Katsura, Y Kawase, I Hatano, H Ishida, T Chiyonobu, Y Kasubuchi, A Morimoto, T Teramura and S Imashuku
Bone Marrow Transplant 31: 1173-1176; doi:10.1038/sj.bmt.1704077
Correspondence
T-cell depletion does not necessarily compromise donor stem cell engraftment in patients receiving reduced-intensity conditioning regimens FREE
C Craddock and A P Grigg
Bone Marrow Transplant 31: 1177; doi:10.1038/sj.bmt.1704099
Reply
Reply to the letter by C Craddock and A P Grigg FREE
J Passweg and A Gratwohl
Bone Marrow Transplant 31: 1179; doi:10.1038/sj.bmt.1704100
Correspondence
Bacteremic cellulitis caused by non-O1, non-O139 Vibrio cholerae in a patient following hematopoietic stem cell transplantation FREE
S M Choi, D G Lee, M S Kim, Y H Park, Y J Kim, S Lee, H J Kim, J H Choi, J H Yoo, D W Kim, W S Min, W S Shin and C C Kim
Bone Marrow Transplant 31: 1181-1182; doi:10.1038/sj.bmt.1704044
Use of recombinant factor VIIa in life-threatening bleeding following autologous peripheral blood stem cell transplantation complicated by platelet refractoriness FREE
D J Culligan, A Salamat, J Tait, G Westland and H G Watson
Bone Marrow Transplant 31: 1183-1184; doi:10.1038/sj.bmt.1704058
Corrigendum
High-dose chemotherapy with autologous stem cell rescue in children with nephroblastoma FREE
B Kremens, B Gruhn, T Klingebiel, C Hasan, H-J Laws, E Koscielniak, B Hero, B Selle, C Niemeyer, F G Finkenstein, A Schulz, A Wawer, F Zintl and N Graf
Bone Marrow Transplant 31: 1185; doi:10.1038/sj.bmt.1704068
Author Index
Author index to Volume 31 FREE
Bone Marrow Transplant 31: 1187-1194; doi:10.1038/sj.bmt.1704175
